GlaxoSmithKline PLC (NYSE:GSK)

46.59
Delayed Data
As of Apr 24
 +0.28 / +0.60%
Today’s Change
41.25
Today|||52-Week Range
56.48
+9.01%
Year-to-Date

Today’s Trading

Previous close46.31
Today’s open46.23
Day’s range46.12 - 46.80
Volume3,279,134
Average volume (3 months)3,463,873
Market cap$113.3B
Dividend yield5.57%
Data as of 4:01pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-9.81%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)-8.75%
P/E ratio41.1
Price/Sales2.71
Price/Book17.05

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.44+0.78%
BMYBristol-Myers Squibb-0.20-0.30%
ACTActavis-2.95-0.99%
ABBVAbbVie+1.82+2.83%
Data as of 4:02pm ET, 04/24/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.54
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers